Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Field
-
Information: 2 openings available. Internal Number: JR89249 Position Summary Functional Genomics of circular RNAs in Alzheimer's Disease. The Cruchaga Lab, member of the NeuroGenomics and Informatics Center, is
-
parallel computing techniques including working in the cloud. Preferred Qualifications Education: No additional education beyond what is stated in the Required Qualifications section. Certifications
-
behavioral paradigms and combined with computational approaches. We are seeking an extremely motivated postdoctoral researcher with background in human or monkey electrophysiology. Studies will include
-
with ab initio methods. Proficiency in software such as VASP, Quantum ESPRESSO, Critic2 and Gibbs2. Experience in high-performance computing and parallel processing. Additional Qualifications Considered
-
closure modeling and/or high performance computing environments (MPI, CUDA) • Expertise in software development and computing tools (C/C++, python, git, parallel computing, etc.) • Experience with deep
-
-learning trained using the van der Waals corrected hybrid density functional theory (DFT) enabled SeA approach [J. Chem. Theory Comput. 19, 4182 (2023)]. The SeA approach is an accurate and efficient high
-
-College of Engineering Department: UNT-Computer Science & Engineering-130310 Job Location: Denton Salary: Competitive salary based on experience FTE: 1.00 Retirement Eligibility: ORP Eligible About Us
-
application development in R and Python Experience with parallel computing Author or co-author of peer-reviewed literature publications Applicants cannot have received their Ph.D. more than five years before
-
protein engineering techniques. In parallel, we are also looking for postdocs interested in developing high-throughput screens for single-domain antibodies, called nanobodies, that perturb intracellular
-
platform enables us to test hundreds of different conditions in parallel and assess their impacts on human immune responses, such as antibody production. We routinely work with industry partners to exploit